CWA Asset Management Group LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 11.9% in ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ...

The market is obsessed with risky options, but disciplined investors know slow and steady wins. Check out three stock picks ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

Eli Lilly's robust product portfolio, strategic acquisitions, and innovation-led initiatives drive its strong growth, positioning it well in the weight-loss, immunology, and oncology markets.

We recently compiled a list of the Tech Billionaire Chase Coleman's Top 10 Stock Picks. In this article, we are going to take ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Jr. on air last week on the floor when ...

Walgreens stock surged 18% on December 10 after reports emerged that it was being sold to a private equity investor. Walgreens is likely discussing a deal with New York-based Sycamore Partners ...

After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on a roller-coaster ride since September. The stock ... at The New York Times’ DealBook ...

Less than two years after the initial announcement, EVA Pharma has completed a new ... Lilly's business that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and ...